Page last updated: 2024-09-03

5-fluorodopamine and fluorodeoxyglucose f18

5-fluorodopamine has been researched along with fluorodeoxyglucose f18 in 9 studies

Compound Research Comparison

Studies
(5-fluorodopamine)
Trials
(5-fluorodopamine)
Recent Studies (post-2010)
(5-fluorodopamine)
Studies
(fluorodeoxyglucose f18)
Trials
(fluorodeoxyglucose f18)
Recent Studies (post-2010) (fluorodeoxyglucose f18)
7681634,7712,16020,111

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's4 (44.44)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Snow, BJ1
Ayala, A; Carrasquillo, JA; Chen, CC; Del Corral, P; Ilias, I; Mamede, M; Pacak, K; Whatley, M1
Carrasquillo, JA; Chen, CC; Hadi, M; Pacak, K; Whatley, M1
de Beco, V; Le Bars, D; Scherrmann, JM1
Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Havekes, B; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M1
Karges, W; Mottaghy, FM; Van Binnebeek, S1
Gesuwan, K; Herscovitch, P; Hughes, MS; Kebebew, E; Kitano, M; Libutti, SK; Linehan, WM; Millo, C; Nilubol, N; Phan, GQ; Rahbari, R; Venkatesan, AM; Webb, RC1
Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Millo, C; Pacak, K1
Blanchet, EM; Bluemke, DA; Maass-Moreno, R; Martucci, V; Millo, C; Pacak, K1

Reviews

2 review(s) available for 5-fluorodopamine and fluorodeoxyglucose f18

ArticleYear
Positron emission tomography in Parkinson's disease.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1992, Volume: 19, Issue:1 Suppl

    Topics: Deoxyglucose; Dopamine; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Tomography, Emission-Computed

1992
[Fluorine-18 in radiopharmacy].
    Annales pharmaceutiques francaises, 2008, Volume: 66, Issue:1

    Topics: Animals; Dopamine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals

2008

Trials

2 trial(s) available for 5-fluorodopamine and fluorodeoxyglucose f18

ArticleYear
Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.
    Surgery, 2011, Volume: 150, Issue:6

    Topics: Adolescent; Adult; Aged; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; von Hippel-Lindau Disease; Young Adult

2011
Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:3

    Topics: Adult; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Injections; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; National Institutes of Health (U.S.); Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed; United States; Whole Body Imaging

2014

Other Studies

5 other study(ies) available for 5-fluorodopamine and fluorodeoxyglucose f18

ArticleYear
Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites.
    Nuclear medicine communications, 2006, Volume: 27, Issue:1

    Topics: 3-Iodobenzylguanidine; Adult; Dopamine; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity

2006
Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:7

    Topics: 3-Iodobenzylguanidine; Adipose Tissue, Brown; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Dopamine; Epinephrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Norepinephrine; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon

2007
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.
    The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:12

    Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult

2009
Functional imaging of neuroendocrine tumors.
    Methods in molecular biology (Clifton, N.J.), 2011, Volume: 727

    Topics: 5-Hydroxytryptophan; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Ephedrine; Etomidate; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Peptides; Positron-Emission Tomography; Radioactive Tracers; Radiopharmaceuticals; Somatostatin

2011
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:12

    Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Bone Neoplasms; Dideoxynucleosides; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radioactive Tracers

2013